The FABP5 protein promotes immune tolerance in patients with HCC by regulating monocytes and tumor-associated monocytes’ fatty acid oxidation process via suppressing the PPARα pathway (J. Liu et al., 2022). Here, FABP5 is linked to hepatocellular carcinoma.